Recruiting Lung Cancer Studies in Elmhurst
A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC
This is a Phase III, randomised, double-blind, placebo-controlled, multicentre, international study assessing the efficacy and safety of durvalumab (MEDI4736) and domvanalimab (AB154) compared with du...
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
This study, known as LUNAR-2, aims to investigate the effectiveness and safety of using TTFields, delivered by the NovoTTF-200T device, concomitantly administered with pembrolizumab and platinum-based...
About Lung Cancer Clinical Trials in Elmhurst
Lung cancer is the leading cause of cancer death worldwide, starting in the cells of the lungs. The two main types are non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Treatments include surgery, chemotherapy, radiation, immunotherapy, and targeted drugs.
There are currently 2 lung cancer clinical trials recruiting participants in Elmhurst, ILLINOIS. These studies are seeking a combined 1,594 participants. Research is being sponsored by AstraZeneca, NovoCure GmbH. Clinical trial participation is free and participants receive study-related medical care at no cost.
Lung Cancer Clinical Trials in Elmhurst — FAQ
Are there lung cancer clinical trials in Elmhurst?
Yes, there are 2 lung cancer clinical trials currently recruiting in Elmhurst, ILLINOIS. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Elmhurst?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Elmhurst research site will contact you about next steps.
Are clinical trials in Elmhurst free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Elmhurst studies also compensate for your time and travel.
What lung cancer treatments are being tested?
The 2 active trials in Elmhurst are testing new therapies including novel drugs, biologics, and treatment approaches for lung cancer.
Data updated March 2, 2026 from ClinicalTrials.gov